Annual report recognizes VC firms with the best returns driving health care innovation
BOSTON, Aug. 21, 2025 -- Today, STAT, the leading health and medicine media company, released its annual STAT Report ranking biotech's top venture capital firms.
This report, the sixth of its kind, gives an unfettered view into biotech VC firms' investing successes or shortcomings, sharing financial figures that are rarely seen by the public. Firms are analyzed on several investment metrics, including whether they have doubled, tripled, or even quadrupled their investors' money.
No one else produces such a sweeping examination of biotech VC operations. It follows a methodology devised by STAT six years ago.
The 2025 Report highlights firms that have demonstrated exceptional performance, strategic vision, and a commitment to supporting groundbreaking health care innovations. These firms have been instrumental in funding startups and companies that are at the forefront of medical research, biotechnology, and digital health.
The report comes as the biotech industry faces a series of existential questions and the National Institutes of Health and other federal forces have slashed scientists' funding, putting the research that venture capitalists invest in in jeopardy. The rise of Chinese biotechs is also stirring anxiety among U.S. startups, and even some investors.
"This annual report is by far our most popular,'' said Rick Berke, STAT's co-founder and executive editor. "It's a deep look into the closed-off world of biotech venture capital — where billions of dollars are being invested every year — that you don't get anywhere else.''
The rankings in this STAT Report are based on comprehensive data obtained and objectively analyzed by the team, and do not reflect STAT's opinion of any firms.
Download the 2025 Edition: Ranking Biotech's Top Venture Capital Firms for an essential guide to understanding the forces driving success in biotech venture capital and unlocking the secrets behind the performance of top-rated firms. The report is available for $499 for an individual copy or available for an additional fee to license the report for an entire company.
This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology.
